These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1685260)
1. Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes. Horn H; Preclik G; Stange EF; Ditschuneit H Scand J Gastroenterol; 1991 Aug; 26(8):867-79. PubMed ID: 1685260 [TBL] [Abstract][Full Text] [Related]
2. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products. Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Nielsen OH; Bukhave K; Elmgreen J; Ahnfelt-Rønne I Dig Dis Sci; 1987 Jun; 32(6):577-82. PubMed ID: 2882965 [TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. Stenson WF; Lobos E J Clin Invest; 1982 Feb; 69(2):494-7. PubMed ID: 6120182 [TBL] [Abstract][Full Text] [Related]
5. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa. Kolassa N; Becker R; Wiener H Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116 [TBL] [Abstract][Full Text] [Related]
6. Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ). Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L Gut; 1990 Jun; 31(6):730-1. PubMed ID: 1974235 [No Abstract] [Full Text] [Related]
7. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation. Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L Dig Dis Sci; 1991 Feb; 36(2):174-8. PubMed ID: 1671010 [TBL] [Abstract][Full Text] [Related]
8. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue]. Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814 [TBL] [Abstract][Full Text] [Related]
9. The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells. Punchard NA; Boswell DJ; Greenfield SM; Thompson RP Biochem Pharmacol; 1992 Jun; 43(11):2369-76. PubMed ID: 1351726 [TBL] [Abstract][Full Text] [Related]
10. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid. Allgayer H; Stenson WF Immunopharmacology; 1988; 15(1):39-46. PubMed ID: 2896181 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of monoHETEs (monohydroxyeicosatetraenoic acids) on arachidonic acid metabolism in glycogen-elicited rat polymorphonuclear leukocytes. Chang J; Skowronek MD; Lewis AJ Inflammation; 1985 Dec; 9(4):395-406. PubMed ID: 3000941 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid. Nielsen OH; Verspaget HW; Elmgreen J Aliment Pharmacol Ther; 1988 Jun; 2(3):203-11. PubMed ID: 2908754 [TBL] [Abstract][Full Text] [Related]
13. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Hawkey CJ; Boughton-Smith NK; Whittle BJ Dig Dis Sci; 1985 Dec; 30(12):1161-5. PubMed ID: 2866075 [TBL] [Abstract][Full Text] [Related]
14. Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds. Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R Biochem Pharmacol; 1993 Jan; 45(1):101-11. PubMed ID: 8381000 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet thromboxane synthetase by sulfasalazine. Stenson WF; Lobos E Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites. Rosolowsky M; Falck JR; Campbell WB Biochim Biophys Acta; 1996 Apr; 1300(2):143-50. PubMed ID: 8652640 [TBL] [Abstract][Full Text] [Related]
17. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2. Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363 [TBL] [Abstract][Full Text] [Related]
18. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes. Dahl ML; Puustinen T; Uotila P Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565 [TBL] [Abstract][Full Text] [Related]
19. Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Henricks PA; Binkhorst GJ; Drijver AA; Nijkamp FP Infect Immun; 1992 Aug; 60(8):3238-43. PubMed ID: 1322370 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes. Wainwright S; Falck JR; Yadagiri P; Powell WS Biochemistry; 1990 Oct; 29(43):10126-35. PubMed ID: 2176862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]